BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 16736518)

  • 1. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
    Mullazehi M; Mathsson L; Lampa J; Rönnelid J
    Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset.
    Mullazehi M; Mathsson L; Lampa J; Rönnelid J
    Ann Rheum Dis; 2007 Apr; 66(4):537-41. PubMed ID: 17040962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis.
    Abrahams VM; Cambridge G; Lydyard PM; Edwards JC
    Arthritis Rheum; 2000 Mar; 43(3):608-16. PubMed ID: 10728755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen.
    Clavel C; Nogueira L; Laurent L; Iobagiu C; Vincent C; Sebbag M; Serre G
    Arthritis Rheum; 2008 Mar; 58(3):678-88. PubMed ID: 18311806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
    Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
    Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts.
    Cho ML; Yoon CH; Hwang SY; Park MK; Min SY; Lee SH; Park SH; Kim HY
    Arthritis Rheum; 2004 Mar; 50(3):776-84. PubMed ID: 15022319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation.
    van Roon J; Wijngaarden S; Lafeber FP; Damen C; van de Winkel J; Bijlsma JW
    J Rheumatol; 2003 Apr; 30(4):648-51. PubMed ID: 12672180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis.
    Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS
    Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
    Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
    Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
    Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
    Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytes.
    Meusch U; Rossol M; Baerwald C; Hauschildt S; Wagner U
    Arthritis Rheum; 2009 Sep; 60(9):2612-21. PubMed ID: 19714631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.